Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 20/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8307027 | 0.89 | AKR1B1 (0.60) | AKR1B1 | |
| SCHEMBL8308299 | 0.86 | AKR1B1 (0.50) | AKR1B1 | |
| SCHEMBL8305041 | 0.86 | AKR1B1 (0.62) | AKR1B1 | |
| SCHEMBL8307514 | 0.86 | AKR1B1 (0.59) | AKR1B1 | |
| SCHEMBL8304577 | 0.84 | AKR1B1 (0.49) | AKR1B1 | |
| SCHEMBL8304753 | 0.83 | AKR1B1 (0.51) | AKR1B1 | |
| SCHEMBL8304109 | 0.81 | AKR1B1 (0.61) | AKR1B1 | |
| SCHEMBL8304641 | 0.80 | AKR1B1 (0.62) | AKR1B1 | |
| SCHEMBL8305341 | 0.79 | AKR1B1 (0.60) | AKR1B1 | |
| SCHEMBL8307068 | 0.77 | AKR1B1 (0.61) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0633261-B1 | QUINOLINE-3-ACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | YOSHITOMI PHARMACEUTICAL (JP) | 1999-04-21 | — | — | EP | disclosed |
| US-5543420-A | ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AGENTS; PREVENTION OF ACCUMULATION OF SORBITOL AND GALACTITOL IN MAMMALIAN TISSUE | THE GREEN CROSS CORPORATION (JP) | 1996-08-06 | — | — | US | disclosed |
| EP-0633261-A1 | QUINOLINE-3-ACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | THE GREEN CROSS CORPORATION (JP) | 1995-01-11 | — | — | EP | disclosed |